Researchers from the Feinstein Institute for Medical Research have recently discovered a link between genetic variations and a person's cognitive ability. An international team of 65 scientists led by Dr. Lencz led the largest peer-reviewed study of its kind and analyzed the genomes of over 400,000 individuals. These individuals took neuropsychological tests to measure their brain function and cognitive ability. By profiling the ability of these individuals, the researchers discovered a genetic predisposition in certain individuals towards higher cognitive ability and longer lifespan. Dr. Lencz explained that this genetic information has the potential to be used to develop targeted treatments for cognitive and memory disorders.
These findings were released two days ago and it is amazing that these researchers performed such a widespread study on the genomes of a large population. This genetic information is beneficial in the development in the treatment for cognitive and memory disorders. It can be used to produce and manufacture new drugs such as Alzheimer's disease, schizophrenia, and attention deficit hyperactivity disorder. While there are many drugs currently available to treat these disorders, novel treatments can be introduced that are more effective.